Literature DB >> 5505522

Reversal of "cirrhosis" in idiopathic haemochromatosis following long-term intensive venesection therapy.

L W Powell, J F Kerr.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1970        PMID： 5505522     DOI： 10.1111/imj.1970.19.1.54

Source DB:  PubMed          Journal:  Australas Ann Med        ISSN： 0571-9283


× No keyword cloud information.
  13 in total

Review 1.  Current and future anti-fibrotic therapies for chronic liver disease.

Authors:  Don C Rockey
Journal:  Clin Liver Dis       Date:  2008-11       Impact factor: 6.126

Review 2.  Pathologic aspects of cirrhosis. A review.

Authors:  H Popper
Journal:  Am J Pathol       Date:  1977-04       Impact factor: 4.307

Review 3.  Iron and the liver.

Authors:  M Barry
Journal:  Gut       Date:  1974-04       Impact factor: 23.059

4.  The Treatment of Hepatic Fibrosis: Reversal of the Underlying Disease Process.

Authors:  Luis Servin-Abad; Eugene R Schiff
Journal:  Gastroenterol Hepatol (N Y)       Date:  2006-11

Review 5.  Fibrosis reversal after hepatitis C virus elimination.

Authors:  Don C Rockey
Journal:  Curr Opin Gastroenterol       Date:  2019-05       Impact factor: 3.287

6.  Regression of hepatic fibrosis in hepatitis C with long-term interferon treatment.

Authors:  J F Dufour; R DeLellis; M M Kaplan
Journal:  Dig Dis Sci       Date:  1998-12       Impact factor: 3.199

Review 7.  Hepatic inflammation and progressive liver fibrosis in chronic liver disease.

Authors:  Albert J Czaja
Journal:  World J Gastroenterol       Date:  2014-03-14       Impact factor: 5.742

Review 8.  Translating an understanding of the pathogenesis of hepatic fibrosis to novel therapies.

Authors:  Don C Rockey
Journal:  Clin Gastroenterol Hepatol       Date:  2013-01-07       Impact factor: 11.382

9.  Regression of fibrosis in paediatric autoimmune hepatitis: morphometric assessment of fibrosis versus semiquantiatative methods.

Authors:  Ahmed F Abdalla; Khaled R Zalata; Abeer F Ismail; Gamal Shiha; Mohamed Attiya; Ahmed Abo-Alyazeed
Journal:  Fibrogenesis Tissue Repair       Date:  2009-04-02

10.  The mitochondria-targeted antioxidant MitoQ attenuates liver fibrosis in mice.

Authors:  Hasibur Rehman; Qinlong Liu; Yasodha Krishnasamy; Zengdun Shi; Venkat K Ramshesh; Khujista Haque; Rick G Schnellmann; Michael P Murphy; John J Lemasters; Don C Rockey; Zhi Zhong
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2016-04-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.